The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limited data are available on the use of miltefosine for treatment and secondary prophylaxis. We describe a case of mucosal leishmaniasis in an HIV-coinfected patient treated with miltefosine due to a severe allergic reaction to liposomal amphotericin B.
Use of miltefosine in a patient with mucosal leishmaniasis and HIV-coinfection: a challenge in long-term management / Zanelli, Giacomo; Rossetti, Barbara; Gagliardini, Roberta; Paglicci, Lorenzo; Tordini, Giacinta; Miracco, Clelia; Aversa, Sara; Zammarchi, Lorenzo; Di Muccio, Trentina; Gramiccia, Marina; Montagnani, Francesca. - In: LE INFEZIONI IN MEDICINA. - ISSN 1124-9390. - 27:4(2019), pp. 452-455.
Use of miltefosine in a patient with mucosal leishmaniasis and HIV-coinfection: a challenge in long-term management
Aversa, Sara;
2019
Abstract
The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limited data are available on the use of miltefosine for treatment and secondary prophylaxis. We describe a case of mucosal leishmaniasis in an HIV-coinfected patient treated with miltefosine due to a severe allergic reaction to liposomal amphotericin B.| File | Dimensione | Formato | |
|---|---|---|---|
|
Zanelli_Use_2019.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
720.9 kB
Formato
Adobe PDF
|
720.9 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
